Advances in diagnosis and treatment of progressive supranuclear palsy and interpretation of new diagnostic criteria
Recently, both the paper "Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches" in Lancet Neurol and "Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria" in Mov Disord attracted much...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tianjin Huanhu Hospital
2018-01-01
|
| Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
| Subjects: | |
| Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/1714 |
| Summary: | Recently, both the paper "Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches" in Lancet Neurol and "Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria" in Mov Disord attracted much attention. In this review, we will discuss the contents in these two papers, including disease progression, features of clinical phenotype, update in diagnostic criteria, biomarkers, and therapeutic status and prospect of progressive supranuclear palsy (PSP), to guide the clinical practice.
DOI: 10.3969/j.issn.1672-6731.2018.01.001 |
|---|---|
| ISSN: | 1672-6731 |